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S U M M A R Y
Ultrasound is increasingly used in point-of-care applications and has great potential to support the
diagnosis of infectious diseases, especially in resource-limited settings. A cross-sectional study was
performed involving 100 Malawian patients with a clinical indication for ultrasound. Furthermore, the
literature on point-of-care ultrasound (POCUS) in Sub-Saharan Africa was reviewed to establish its
applicability, most frequent indications, findings, and implications for treatment, and therefore
relevance in POCUS curricula, with a main focus on infectious diseases. In Malawi, the main indications
for ultrasound were weight loss, abdominal pain, and shortness of breath. Abnormal findings were
observed in 77% of patients, the most common being enlarged abdominal lymph nodes (n = 17),
pericardial effusion (n = 15), splenicmicroabscesses (n = 15), and pleural effusion (n = 14). POCUS led to a
change in treatment in 72% of patients. The literature on the various POCUS applications used in Malawi
was reviewed, including focused assessment with sonography for HIV-associated TB (FASH), heart, liver,
kidney, deep venous thrombosis (DVT), and gynaecology. Based on disease prevalence, impact of POCUS
on treatment, and technical difficulty, it is proposed that FASH, heart, and DVT are the most relevant
POCUS applications in comparable Sub-Saharan African settings and should be incorporated in POCUS
curricula.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Ultrasound (US) is applied as a diagnostic aid and to guide
therapy in a vast number of tropical infectious diseases.1,2 [1_TD$DIFF] In
Malawi, it was found to be particularly useful in inpatients with
HIV infection.3 During the past two decades, technological
advances have improved image quality and have significantly
reduced the size and price of US equipment. As a result, US is* Corresponding author. Tel.: +265 885832022.
E-mail address: echnatom@web.de (T. Heller).
http://dx.doi.org/10.1016/j.ijid.2016.11.001
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).increasingly applied at the point of care for clinical decision-
making and to provide procedural guidance.4 Emergencymedicine
physicians have pioneered and greatly advanced the point-of-care
applications of US (POCUS). The ‘focused assessment with
sonography for trauma’ (FAST) protocol has become well recog-
nized as a standardized diagnostic test in emergency depart-
ments.5 Other specialties, including infectious diseases (ID), are
beginning to utilize POCUS.6
The fundamental difference between POCUS and conventional
US examinations is that POCUS is performed by the treating
physician who aims at answering simple, usually binary questions
relevant to immediate patient management (e.g., ‘‘Is there aciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
T. Heller et al. / International Journal of Infectious Diseases 56 (2017) 229–236230pericardial effusion, yes or no?’’). It has been demonstrated that
physicians can perform accurate US scanswith a limited amount of
training.5 Formal training programs have been developed to teach
US skills within the framework of an emergency medicine
curriculum,7 while the development of POCUS training programs
in ID is still in its infancy. In ID, individual applications are taught in
short courses,8 but a standardized curriculum has never been
developed and most curricula are collated following the opinions
and preferences of local leaders in the field. The selection of POCUS
applications for a particular setting should apply three criteria: (1)
the condition should be prevalent in the patient population; (2) its
diagnosis should carry the potential to significantly change patient
management; and (3) POCUS diagnosis should be fairly straight-
forward for a novice to learn.9
In this study, the frequency of use of various POCUS
applications, findings, and consequences for treatment were
assessed in urban Malawi, a setting with high tuberculosis (TB)
and human immunodeficiency virus (HIV) prevalence. The
literature on common US applications was then reviewed,
including focused assessment with sonography for HIV-associated
TB (FASH), heart, liver, kidney, deep venous thrombosis (DVT), and
gynaecology. Their applicability, most frequent indications, find-
ings, and possible implications for treatment in the resource-
limited setting in Sub-Saharan Africa were assessed. Finally, a
ranking is provided to inform local POCUS curriculum develop-
ment. The aim is to present an objective and targeted approach to
determine an epidemiologically and clinically relevant curriculum
in this setting.
2. Methods
2.1. Clinical setting
POCUS scans were performed in four different clinical settings
in Lilongwe, Malawi: two integrated HIV and TB outpatient clinics
operated by the Lighthouse Trust, the internal medicine ward of
Kamuzu Central Hospital (KCH), and the TB ward at Bwaila
Hospital.
Both HIV outpatient clinics of the Lighthouse Trust, a World
Health Organization (WHO) recognized centre of excellence for
HIV care, provide integrated HIV testing, treatment, and care.
Lighthouse Clinic (LH) on the campus of KCH currently provides
care for approximately 10 000 registered HIV patients on
antiretroviral therapy (ART). Martin Preuss Clinic (MPC) at Bwaila
Hospital (Lilongwe District Health Office) currently provides care
for just over 19 000 HIV patients on ART. The two clinics combined
register an average of 750 patient-visits per day. LH serves as a
primary and secondary centre, as well as being a tertiary referral
centre for other ART clinics within Lilongwe and the central region
of Malawi. The integration of TB and HIV services is a key priority;
all patients starting ART are clinically screened for TB. LH and MPC
are recognized TB treatment sites and manage TB patients as
outpatients in accordance with the Malawi National TB guidelines.
LH, which is predominantly an ART site, has a smaller TB treatment
service; in 2015, 81 TB patients were registered (63 pulmonary TB
(PTB) patients (97% HIV-positive) and 18 extrapulmonary TB
(EPTB) patients (94% HIV-positive)). MPC treats the largest cohort
of TB patients in Malawi (2015: 1000 PTB patients (61% HIV-
positive) and 322 EPTB patients (63% HIV-positive)).
KCH is the tertiary referral hospital in Lilongwe for the central
region ofMalawi. The internalmedicine department of KCH admits
approximately 250–300 patients everymonth. Around one third of
inpatients are HIV-infected, with a third of these being newly
diagnosed with HIV and two thirds being on, or having been on,
ART. The LH team supports the HIV and TB diagnostics and
treatment of inpatients. Diagnostic services available are generallyrestricted; TB diagnostics include smear microscopy and GeneX-
pert. Plain X-ray, computed tomography (CT), and US are available
as imaging modalities.
The TB ward at Bwaila hospital predominantly treats TB re-
treatment cases requiring injectable drugs and TB patients who are
otherwise too sick to be treated on an outpatient basis. On average,
20–25 patients are admitted at any time, most of them for a
2-month period.
2.2. Patients
A cross-sectional study was performed in adult patients (age
15 years) for whom the treating clinician established an
indication for US. All examinations were performed in duplicate
by two clinicians (TH and EAM). A portable black-and-white
scanner with a 3.5-MHz convex probe and a 7-MHz linear probe
was used (DP-30; Mindray, China). A convenience sample of
100 consecutive US examinations was collected prospectively and
analyzed. For scanned patients, demographic information and HIV
data were recorded; indications for US examination, relevant
findings, and therapy adjustment following examination were
noted. The US procedures were summarized by one or more key
terms, hereafter called ‘applications’.
2.3. Ethics
As examinations were part of routine care, no informed consent
was sought. The extraction and analysis of the clinical data were
covered under the Lighthouse blanket Ethics and Research
Approval from the National Health Sciences Research Committee
(NHSRC) of Malawi.
2.4. Literature review
Based on the selection of US applications relevant in this patient
cohort in Malawi, the literature was reviewed for information
about indications, applicability, and consequences for treatment of
these applications in the settings of Sub-Saharan Africa.
3. Results
POCUS examination data of 100 patients were recorded over a
2-month period (June to August 2016). Baseline characteristics and
clinical indications for POCUS are presented in Table 1.
The most frequent reason for POCUS was loss of weight (or
cachexia), followed by abdominal pain and shortness of breath.
Abnormal findings on US were found in 77% of patients, and there
was a change in treatment following POCUS in 72% of patients
(Table 2). The initiation of TB treatment was the most common
treatment change resulting from POCUS, followed by the initiation
of ART, mostly in patients in whom no sign of TB was found. Other
treatment changes, such as initiation of antibiotic therapy or
anticoagulation, were common for specific indications such as
abdominal pain and suspected DVT, respectively (Table 2). POCUS
examinations were grouped into six applications; their description
and frequency are shown in Table 3. FASHwas themost frequently
used POCUS application, followed by ‘heart’ and ‘liver’. ‘Kidney’,
‘DVT’, and ‘gynaecology’ were recorded in fewer than 10 patients.
4. Discussion and literature review
POCUS is a frequently used diagnostic modality in the present
patient population with a high prevalence of HIV and TB, and
contributed to a change in treatment in 72% of the study patients.
The high rate of positive findings, and consequent treatment
changes, can be explained by the fact that a selected population
Table 1
Baseline characteristics and indications for POCUS in Malawian patients
Total
n=100
HIV-positive
n=83
HIV-negative
n=17
Male sex, n 42 35 7
Age, years, median (IQR) 34 (25–44) 33 (24–42) 38 (25–51)
Location of patient, n (%)
Internal medicine ward 44 38 (86) 6 (14)
ART clinic 37 36 (97) 1 (3)
TB clinic 11 4 (36) 3 (17)
TB ward 8 5 (63) 3 (17)
On ART (% of HIV-positive) 74 [3_TD$DIFF] (89)
ART started in last 6 months 30[4_TD$DIFF] (36)
ART started in last
6–12 months
4[5_TD$DIFF] (5)
ART started in last
12–24 months
5[6_TD$DIFF] (6)
On ART for over 24 months 35 [7_TD$DIFF] (42)
On TB treatment, n 8 8 0
Indications for scanning, n (%)
Weight loss 37 36 (97) 1 (3)
Abdominal paina 20 19 (95) 1 (5)
SOB 15 12 (80) 3 (20)
Cardiomegaly 11 7 (63) 4 (37)
Cough 11 10 (91) 1 (9)
Jaundice 10 9 (90) 1 (10)
Chest pain 9 6 (67) 3 (33)
Organomegaly palpable 8 7 (87) 1 (13)
Bilateral leg oedema 6 4 (67) 2 (33)
Suspected ascites 5 3 (60) 2 (40)
Unilateral leg swelling 5 4 (80) 1 (20)
Abnormal CXR 4 3 (75) 1 (25)
Elevated LFT 4 4 (100) 0 (0)
Renal failure 2 1 (50) 1 (50)
Herpes zoster 1 1 (100) 0 (0)
POCUS, point-of-care applications of ultrasound; IQR, interquartile range; ART,
antiretroviral therapy; TB, tuberculosis; SOB, shortness of breath; CXR, chest X-ray;
LFT, liver function test. All percentages refer to the total number of patients per row.
a Abdominal pain includes right upper quadrant pain, flank pain, and lower
abdominal pain in female patients.
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and patients who had been on ART for less than 6 months (n = 30),
in whom opportunistic infections and unmasking immune
reconstitution inflammatory syndrome (IRIS) are frequently seen.
Furthermore, the study centre serves as a tertiary referral centre
and may therefore receive a preselected population with more
severe illness. Nevertheless, it is believed that the US applications
used in the present cohort can be applied in various settings. The
applications are discussed individually below, and conclusions are
drawn on the relevance of different POCUS applications in a
curriculum in Sub-Saharan African settings with a similar high
prevalence of HIV and TB.
4.1. Focused assessment with sonography for HIV-associated TB
(FASH)
People living with HIV are 20 to 30 timesmore likely to develop
active TB, and one in three HIV deaths is due to TB.10 TB mainly
causes pulmonary disease, but can disseminate to extrapulmonary
sites such as lymph nodes, pleurae, pericardium, and abdominal
cavity, especially in HIV-infected patients.11,12 The diagnosis of
EPTB is hampered by difficulties in obtaining adequate samples
and the limited availability and low sensitivity of diagnostic tests.
FASH screens the patient for sonographic findings that suggest
EPTB and can support the presumptive diagnosis of EPTB,
especially in HIV-infected patients in endemic settings.13 Impor-
tant findings include pleural effusion, pericardial effusion, free
intra-abdominal fluid, enlarged abdominal lymph nodes, and
microabscesses in the liver or spleen. Pleural effusions present as
anechoic fluid, in the costophrenic angles, with or without
fibrinous strands. In particular, unilateral effusions are highlysuggestive of TB.14 Pericardial effusions usually present as an
anechoic rim around the heart (Figure 1), and in Sub-Saharan
Africa, this is associated with TB in the majority of cases.3
Tuberculous peritonitis can present with ascites, with or without
fibrin strands, and is most likely seen in Morrison’s (hepato-renal)
pouch, the spleno-renal pouch, or pouch of Douglas.13 Enlarged
abdominal lymph nodes present as round, hypoechoic structures;
lymph nodes larger than 1.5–2.0 cm are considered pathological
(Figure 2a). TB lymph nodes are commonly found in the
epigastrium, the para-aortic region, mesenterium, and the splenic
hilum.13 Finally, microabscesses in the liver and particularly in
the spleen present as small, round, hypoechoic lesions in the
parenchyma (Figure 2b).13 Data from various settings have shown
that in a quarter of patients with FASH findings suggestive of EPTB,
no signs of TB are seen on chest X-ray (CXR),15 demonstrating the
added value of FASH in prompting the initiation of anti-TB
treatment. In South Africa, a country with a high prevalence of TB
and HIV, FASH is among the most commonly used POCUS
applications.9 Detecting fluid in pleura,16 pericardium,17 and
abdomen5 can be considered as technically ‘easy’. The detection
of enlarged lymph nodes and splenic microabscesses is slightly
more difficult, but can still be taught in short courses.8
4.2. Heart
Dyspnoea is a frequent reason for patients to seek medical
attention and was one of the main indications for US in the present
patient cohort. US constitutes an excellent tool to diagnose cardiac
conditions causing dyspnoea and to differentiate between differ-
ent conditions causing an image of cardiomegaly on CXR.3 In the
15 patients with dyspnoea in the present study, a cardiac cause
was found in seven patients. US of the heart generally uses four
views: the subxyphoid view (which is also included in the FASH
protocol), the left parasternal long axis and short axis views, and
the apical four-chamber view.18 It has been demonstrated that
non-cardiologists can reliably estimate left ventricle (LV) function
by ultrasound.19 Considering the different findings, the present
authors would grade the difficulty of sonographic assessment of
the heart as ‘moderate’.
4.2.1. Pericardial effusion
Tuberculous pericarditis is by far the commonest cause of
pericardial effusion in Sub-Saharan Africa.20 Other important
causes of large pericardial effusions, especially in HIV-infected
patients, include pyogenic infection, lymphoma, and Kaposi’s
sarcoma.21,22 Pericardial effusions are usually assessed using the
subxyphoid view. In addition, the parasternal long axis view can
be helpful to differentiate between pleural and pericardial fluid, as
pleural effusions do not cross the descending aorta while
pericardial effusions do.18 Tamponade is characterized by diastolic
collapse of the right atrium or ventricle and requires urgent
pericardial drainage, which can be performed in the resource-
limited setting.23
4.2.2. Cor pulmonale
Right heart failure is an important cause of morbidity in Sub-
Saharan Africa; in a South African study, it was found to be the
cause of heart failure in 27% of 844 new cases.24 A study among
HIV-infected patients with cardiac symptoms in Tanzania ob-
served pulmonary hypertension in 12.7% of 102 cases.25 Infectious
diseases like HIV, schistosomiasis, and TB, haemoglobinopathies,
and air pollution are thought to play an important role in the
pathophysiology of cor pulmonale in Sub-Saharan Africa.20,26 The
apical four-chamber view is best suited to assess the relative
dimensions of the LV and right ventricle (RV). A RV/LV ratio >0.7
indicates a dilated RV. In addition, movement of the septum away
Table 2
Indications for scanning, related abnormal findings, and treatment consequences
Reason for scan Total
patients, n
Patients with
abnormal
findings, n (%)
Most common abnormal
findings, n (%)
Patients with
treatment
change, n (%)
Most common treatment changes, n (%)
Total 100 77 (77) Enlarged abdominal LN, 17 (17)
Pericardial effusion, 15 (15)
Spleen microabscesses, 15 (15)
Pleural effusion, 14 (14)
72 (72) Start TB treatment, 23 (23)
ART initiation/change, 10 (10)
Diuretics/antihypertensives, 10 (10)
Liver/LN/pleura biopsy, 5 (5)
Weight loss 37 29 (78) Enlarged abdominal LN, 13 (35)
Spleen microabscesses, 12 (32)
Pericardial effusion, 8 (22)
Pleural effusion, 6 (16)
Ascites, 4 (11)
28 (76) Start TB treatment, 18 (49)
ART initiation/change, 8 (22)
Abdominal pain 20 18 (90) Enlarged abdominal LN, 7 (35)
Spleen microabscesses, 3 (15)
Ascites, 3 (15)
Adnexal mass/EP, 3 (15)
Bowel wall thickening, 3 (15)
15 (75) Start antibiotic treatment 5 (25)
Start TB treatment, 3 (15)
Gynaecology/surgery referral, 3 (15)
SOB 15 11 (73) LV dysfunction, 4 (27)
Pleural effusion, 3 (20)
Cor pulmonale, 3 (20)
Pericardial effusion, 2 (13)
Lung infiltrate, 2 (13)
11 (73) Diuretics/antihypertensives, 5 (33)
Various othera, 8 (53)
Cardiomegaly 11 9 (81) LV dysfunction, 4 (36)
Pericardial effusion, 3 (27)
Pleural effusion, 2 (18)
Cor pulmonale, 1 (9)
7 (64) Diuretics/antihypertensives, 4 (36)
Start TB treatment, 2 (18)
Steroids, 1 (9)
NSAIDs, 1 (9)
Cough 11 10 (91) Pleural effusion, 4 (36)
Pericardial effusion, 4 (36)
Spleen microabscesses, 3 (27)
Lung infiltrate, 3 (27)
8 (72) Start TB treatment, 6 (54)
Diuretics/antihypertensives, 2 (18)
ART initiation/change, 2 (18)
Jaundice 10 8 (80) HCC/CCC, 3 (30)
Cirrhosis, 3 (30)
Biliary dilatation, 3 (30)
7 (70) Liver/LN/pleura biopsy, 2 (20)
ART initiation/change, 2 (20)
Various otherb, 3 (30)
Chest pain 9 7 (78) Pleural effusion, 4 (44)
Pericardial effusion, 4 (44)
Spleen microabscesses, 1 (11)
8 (89) Start TB treatment, 5 (55)
Liver/LN/pleura biopsy, 1 (11)
Steroids, 1 (11)
NSAIDs, 1 (11)
Organomegaly 8 8 (100) Hepato/splenomegaly, 3 (38)
HCC/CCC, 3 (38)
Various otherc, 5 (63)
6 (75) ART initiation/change, 3 (38)
Liver/LN/pleura biopsy, 2 (25)
Start TB treatment, 1 (13)
Praziquantel, 1 (13)
Bilateral oedema 6 5 (83) LV dysfunction, 2 (33)
Various otherd, 5 (83)
5 (83) Diuretics, 2 (33)
Various othere, 3 (50)
Suspected ascites 5 5 (100) Ascites, 2 (40)
Cirrhosis, 2 (40)
Various otherf, 2 (40)
4 (80) Variousg, 5 (100)
Unilateral leg swelling 5 3 (60) DVT, 3 (60)
Enlarged abdominal LN, 2 (40)
Spleen microabscesses, 2 (40)
Pericardial effusion, 1 (20)
4 (80) Anticoagulation, 3 (60)
ART initiation/change, 3 (38)
Liver/LN/pleura biopsy, 2 (25)
Start TB treatment, 1 (13)
TB, tuberculosis; ART, antiretroviral treatment; LN, lymph nodes; EP, ectopic pregnancy; SOB, shortness of breath; LV, left ventricle; NSAIDs, non-steroidal anti-inflammatory
drugs; HCC, hepatocellular carcinoma; CCC, cholangiocarcinoma; DVT, deep venous thrombosis. All percentages refer to the total number of patients per row. Some patients
hadmore than one reason for scanning, more than one outcome, or more than one change in treatment. Indications that occurred in fewer than five patients are omitted from
this table. These included elevated liver biochemistry (n=4), an abnormal chest X-ray (n=4), renal failure (n=2), and herpes zoster (n=1).
a Including start of TB treatment, start of antibiotics, pleural biopsy, steroids, Kaposi sarcoma treatment, digoxin, and bronchodilators.
b Including stopping TB treatment, start of hyoscine butylbromide, and further diagnostics with hepatitis B serology and alpha-fetoprotein.
c Including enlarged abdominal lymph nodes, cirrhosis, ascites, pericardial effusion, biliary dilatation, and schistosomiasis.
d Including pleural effusion, pericardial effusion, spleen microabscesses, cirrhosis, and cor pulmonale.
e Including start of TB treatment, further diagnostics with hepatitis B serology and alpha-fetoprotein, and digoxin.
f Including LV dysfunction and an adnexal mass.
g Including start of ART, diuretics, diagnostics with hepatitis B serology and alpha-fetoprotein, and referral to a gynaecologist.
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resulting in a ‘D’-shaped LV in the parasternal short axis.18
Treatment will be aimed at the underlying disease and at
symptomatic relief of over-hydration by diuretics.
4.2.3. Dilated cardiomyopathy (DCM)
DCM is a common pathology of advanced HIV infection27 and
presents with shortness of breath, hypotension, and shock in
advanced disease. In Sub-Saharan Africa, DCM is a common cause
of heart failure, ranging from 9.8% of patients with cardiac
symptoms in Tanzania,25 to 28% of heart failure patients in SouthAfrica.28 Other important causes of cardiomyopathy in Sub-
Saharan Africa include familial disease, alcoholism, and peripar-
tum cardiomyopathy.20
DCM can be recognized on US using the subxyphoid view, or the
apical four chamber view. Dilatation of all four chambers can be
observed, and reduced inward endocardial systolic motion, which
can be recognized by sonographers with limited experience.19 To
evaluate different causes of shock, measurement of the inferior
vena cava (IVC) is incorporated as part of the RUSH protocol (rapid
ultrasound in shock).29 A patient in shock with a hyperdynamic LV
with a small IVC (<1.5 cm) requires aggressive fluid resuscitation,
Table 3
POCUS applications used during the examination of 100 patients in a Malawian high prevalence HIV and TB setting
Application Description Frequencya [8_TD$DIFF]
1 FASH Assessment using six sonographic planes for effusions (pericardial, pleural, ascites), intra-abdominal LNs, and
microabscesses in the spleen and liver as signs of EPTB in patients with constitutional symptoms
60
2 Heart Assessment of the heartmainly from the epigastric angle for signs of pericardial effusion and tamponade, reduced LV
function, and cor pulmonale as explanations for cardiomegaly, oedema, and SOB
20
3 Liver Assessment of the liver for signs of cirrhosis, biliary obstruction, and focal lesions in theworkup of jaundice, elevated
LFTs, palpable organomegaly, and abdominal pain and fever
17
4 Kidney Assessment of the kidneys looking for urinary tract obstruction and HIVAN as an explanation for flank pain and
impaired renal function
8
5 DVT Compression US of the inguinal and popliteal veins to diagnose DVT in patients with (unilateral) leg swelling 5
6 Gynaecology Assessment of the lower (female) abdomen in cases of lower abdominal pain for intrauterine and extrauterine
pregnancy, free fluid, and adnexal masses (PID)
5
POCUS, point-of-care applications of ultrasound; TB, tuberculosis; FASH, focused assessment with sonography for HIV-associated TB; LN, lymph node; EPTB, extrapulmonary
tuberculosis; LV, left ventricle; SOB, shortness of breath; LFT, liver function test; HIVAN, HIV-associated nephropathy; US, ultrasound; DVT, deep vein thrombosis; PID, pelvic
inflammatory disease.
a Sum is >100, as more than one application could be chosen per patient.
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requires diuretics and, if available, inotropes.18,29 Additionally
angiotensin-converting enzyme (ACE) inhibitors and aldosterone
antagonists may be available for the treatment of patients with
cardiomyopathy.
4.3. Liver
The liver, the largest solid organ, is the organ most often
scanned by US in internal medicine patients in resource-limited
settings.30 In the present patient cohort, abdominal pain, jaundice,
and organomegaly were common indications for liver US. The
complex liver anatomy, the wide variety of possible findings, and
the broad differential diagnosis require a high level of expertise.
Biliary dilatation, cirrhosis, and focal liver lesions are the three
major findings of relevance to HIV-infected patients.
4.3.1. Focal liver lesions
Focal liver lesions can be due to infections as well as malignant
and benign tumours. Focal TB abscesses are found in HIV co-
infected individuals,15,31 and are also well-described in patients
without immunodeficiency. Tuberculomata may also be detected
as part of disseminated TB disease when lymphadenopathy and
spleen abscesses are present concomitantly.15 Amoebic liver
abscesses occur in HIV-infected patients, but whether HIV
infection is a risk factor for invasive amoebiasis remains
controversial.32,33 Typical US findings of liver abscesses are focal
areas of different echogenicity within the liver parenchyma (which
in most cases is hypoechoic) compared to the surrounding liver
[(Figure_1)TD$FIG]
Figure 1. Pericardial effusion in a patient with TB pericarditis: an anechoic, black
stripe around the heart separating the visceral and parietal pericardium (arrows).tissue, as pus or necrotic material has generally lower echogeni-
city.13 In isolated cases, abscesses can also be iso- or hyperechoic.
The detection of focal hypoechoic hepatic lesions is possible
even for less experienced sonographers if the lesions are located in
a sonographically accessible area of the liver, and it is therefore
integrated in the FASH protocol.8 Positive findings can be used in
conjunction with the clinical picture to diagnose an abscess, which
can be treated successfully. Nevertheless, it is difficult to rule out a
focal process as it may easily be overlooked if small or located in
less accessible areas like the subphrenic segments of the liver.
Combined with the wide differential diagnosis of liver masses, the
examination may often require input from an experienced
sonographer.
4.3.2. Liver cirrhosis
Jaundice is a frequent sign in patients with HIV and TB for a
variety of reasons. Common causes are liver cirrhosis, flares of
hepatitis B,34 and ‘drug-induced liver injury’ (DILI) due to TB drugs
and ART. Liver cirrhosis is prevalent in HIV-infected patients,
frequently due to co-infection with hepato-tropic viruses like
hepatitis B virus35 and hepatitis C virus.36 In patients with HIV co-
infection, the progression from fibrosis to cirrhosis due to hepatitis
is accelerated compared to patients without HIV co-infection.37
Ruling in cirrhosis may influence treatment decisions, as it makes
DILI less likely. Sonographic signs of cirrhosis can be subtle and in
early stages undetectable; to rule out early liver cirrhosis by US is
therefore not possible. Signs of advanced cirrhotic changes are (1) a
nodular liver surface, best seen in the presence of ascites; (2)
changes in the vasculature with amputated portal branches and a
prominent central portal vein; (3) a coarse inhomogeneous echo
pattern of the liver tissue; and (4) possibly an enlarged caudate
lobe. Changes in the liver surface and vasculature may be
discernable by a less experienced sonographer. Nevertheless, the
sonographic diagnosis of cirrhosis must be considered as ‘difficult’.
4.3.3. Biliary dilatation
Dilatation of the intra- and extra-hepatic bile ducts is another
explanatory finding in patients with jaundice and elevated liver
enzymes. In the industrialized setting, these changes are mainly
due to gallstones or tumours obstructing the bile flow,38 but the
differential diagnosis in HIV/TB patients is different. Obstruction
by enlarged tuberculous lymph nodes may cause dilatation of the
bile ducts and pancreatic duct.39 HIV-associated cholangiopathy
has to be considered in cases of segmental or general dilatation of
the duct system.40 The sonographic features of dilated bile ducts
are anechoic tubular structures running parallel to the portal
venous system. This is often described as ‘double-barrel’ or ‘shot-
gun’ sign. Although the US picture is clear, well described, and
[(Figure_2)TD$FIG]
Figure 2. (a) Enlarged para-aortal abdominal lymph nodes due to abdominal TB are seen as hypoechoicmasses (arrows). (b)Multiple hypoechoicmicroabscesses of the spleen
in a patient with disseminated TB (arrowheads).
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obstructing tuberculous nodes normally respond to treatment,
treatment options for cholangiopathy are limited in the absence of
advanced endoscopic services.
4.4. Kidney
Renal problems are frequent in tropical settings41 and US is the
imaging modality of choice to assess the kidneys. Common
indications for kidney POCUS are flank pain and reduced renal
function.42
Flank painmay be caused by urinary tract obstruction. Enlarged
tuberculous lymph nodes are a well-known cause of compression;
enlarged lymph nodes may also be due to cervical cancer or
lymphoma.43 In renal TB, dilatation of calyces and the renal pelvis,
sometimes containing debris, can be found, as well as calcification
and thickening of the ureter.44 In patients receiving the protease
inhibitor atazanavir, which iswidely used today in second-line ART
regimens in Africa, precipitation of crystals in kidney tubules with
consecutive formation of stones obstructing the urinary tract are
well described.45 POCUS to detect urinary tract obstruction is well
described;46 its use is widely accepted and considered relatively
easy. Therapeutic options in the resource-limited setting are
usually limited to analgesia and increased fluid intake.
Renal failure is also a well-known complication in HIV patients,
as a result of HIV-associated nephropathy (HIVAN) and nephro-
toxic medication, such as tenofovir, which is used widely in first-
line ART regimens.47,48 Sonographically, HIVAN is often character-
ized by slightly enlarged kidneys with an echogenic cortex and
decreased cortico-medullary definition.49,50 In a setting where
biopsy is not available, proteinuria and these sonographic findings
may be sufficient to make a presumptive diagnosis.43 In untreated
HIV-patients, ART should be initiated. Additionally, the concomi-
tant prescription of an ACE inhibitor is a treatment option. The
sonographic assessment of causes of renal impairment is less
straightforward for the beginner and is considered ‘moderate’.
4.5. Deep venous thrombosis
There is a paucity of literature on thromboembolic disease in
Sub-Saharan Africa. The few studies available suggest it is an
important problem, while prophylaxis is under-used.51,52 Patients
with HIV and/or TB are likely to have an increased risk for
thromboembolic disease, as both HIV and TB activate the
coagulation system, damage endothelium, and impair anticoagu-
lant mechanisms.53–55 A study in Kenya demonstrated that HIVand pulmonary TB were frequent comorbidities in patients with
pulmonary embolism (10.9% and 12.5%, respectively).56 Therefore,
the application of US for the diagnosis of DVT is relevant in Sub-
Saharan Africa.
A simplified POCUS protocol to screen for DVT has been
developed by emergency physicians and includes assessment of
the common femoral vein and popliteal vein.57 Thrombosis is
identified when the vein is not compressible while applying
enough pressure to deform the adjacent arterial wall. This can be
assessed reliably by emergency physicians57,58 and can be
considered ‘easy’. In the present cohort, DVT was observed in
three out of five patients with unilateral leg swelling, which had
immediate consequences for treatment. The treatment of DVT by
anticoagulation can prevent pulmonary embolism and leads to
resolution of the thrombus. The implementation of anticoagulation
monitoring may be challenging in resource-limited settings,
particularly as drug interactions with TB drugs and ART are
frequent. Nevertheless, good performance of a pharmacist-
managed anticoagulation clinic was demonstrated in rural
Kenya.59 Furthermore, the implementation of novel anticoagulant
therapies, which do not warrant monitoring, could facilitate the
management of thromboembolism in Sub-Saharan Africa.
4.6. Gynaecology
Pelvic inflammatory disease (PID) and ectopic pregnancy are
common gynaecological problems in HIV-infected women. In Sub-
Saharan Africa, 17–40% of gynaecology admissions are due to
PID.60 The symptoms may vary from asymptomatic to abnormal
vaginal discharge, lower abdominal pain, cervical motion tender-
ness, and fulminant infection with fever and peritonitis. Ectopic
pregnancy is the leading cause of maternal death in the first
trimester,61,62 with a very high case-fatality rate in the developing
world.63
Clinical and laboratory findings often suffice to diagnose PID
and initiate treatment, but trans-abdominal US is a useful
diagnostic tool in cases with unexplained symptoms, chronic
PID, and complicated cases, such as tubo-ovarian abscess. Trans-
vaginal US has a higher sensitivity and provides a more detailed
view of the uterus and adnexa, but is not readily available outside
gynaecology departments, is technicallymore difficult, and is often
not required to establish the diagnosis. In women with a suspicion
of PID, one should look for enlargement of the uterus and/or
adnexa, free fluid in the pouch of Douglas, fluid in the cavum uteri,
and increased echogenicity of the pelvic fat. Salpingitis can present
with hyperechoic structures surrounded by a hypoechoic rim of
Table 4
Weighting of prevalence, diagnostic impact, and difficulty of POCUS applications
Weight Disease prevalence Diagnostic impact of US US difficulty
1 Rare Minor or no treatment change Advanced
2 Relatively common Treatment change Moderate
3 Very common Urgent treatment change
(possibly life-threatening)
Easy
POCUS, point-of-care applications of ultrasound; US, ultrasound.
Table 5
Weighting model applied to POCUS applications in high-prevalence HIV and TB
settings
Module Prevalence
(P)
Impact
(I)
Difficulty
(D)
P ID Relative
weight
Rank
FASH 3 3 2 18 0.40 1
Heart 2 3 2 12 0.27 2
DVT 1 2 3 6 0.13 3
Liver 2 2 1 4 0.09 4
Gynaecology 1 3 1 3 0.07 5
Kidney 1 1 2 2 0.04 6
Total 45 1.00
POCUS, point-of-care applications of ultrasound; TB, tuberculosis; FASH, focused
assessment with sonography for HIV-associated TB; DVT, deep venous thrombosis.
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multi-loculated, cystic structure, possibly with a wall.
Urinary beta human chorionic gonadotropin (b-HCG) plus a
trans-abdominal US are simple and inexpensive diagnostic tests
for ectopic pregnancy, therefore it should be used in all women of
childbearing age with lower abdominal pain. The diagnostic
approach is to search for an intrauterine pregnancy, as a positive
urinaryb-HCGwithout a visible intrauterine pregnancy is virtually
diagnostic for ectopic pregnancy. Only after this should the
sonographer look for the ectopic pregnancy itself. Ninety-five
percent of ectopic pregnancies develop in the Fallopian tubes;64
however, they also occur in the ovaries, cervix, and peritoneal
cavity andmay not always be found.65 Free abdominal fluid should
be looked for, which can be present in ruptured and non-ruptured
ectopic pregnancies, with the larger quantities usually seen after
rupture.
While the difficulty of sonographic diagnosis of ectopic
pregnancy (or the absence of intrauterine pregnancy) may be
considered as ‘moderate’, the visualization of adnexa and abscesses
usually requires more advanced US skills. Treatment implications
are antibiotic treatment for PID and referral to surgery for ectopic
pregnancy.
4.7. Training implications
Defining POCUS curricula is important for a targeted allocation
of training resources. Based on the experience with US in the
present patient cohort in Malawi and the review of the literature, a
ranking of the most relevant POCUS applications is proposed. To
assess relevance, a method proposed by van Hoving et al. was
followed.9 Weights are assigned to three components (prevalence,
impact, and difficulty) for each of the POCUS applications (Table 4).
Next, a ‘relative weight’ of each application is calculated to rank
them (Table 5). According to this ranking, FASH is the module with
the most favourable balance between prevalence (as it is very
frequent in HIV/TB endemic settings), impact (as it has significant
effects on management), and difficulty (the detection of effusions
can be considered ‘easy’, although the detection of enlarged lymph
nodes and spleen abscesses was considered ‘moderate’). Although
thismultifactorial weightingmodel has not yet been validated, it is
easy to use and to apply. Therefore, it has the potential to inform
decisions about a relevant POCUS curriculum in various settings.5. Conclusions
These data from Malawian patients with a high prevalence of
HIV and TB demonstrate that POCUS is a very useful tool in the
resource-limited setting, in particular to aid the diagnosis of EPTB,
but also other conditions such as heart failure, adnexal masses and
ectopic pregnancy, hepatocellular carcinoma, and DVT. POCUS
informed a change in treatment in a large proportion of the
patients. A further review of the literature illustrated the relevance
and applicability of various POCUS applications including FASH,
heart, DVT, liver, gynaecology, and kidney. Based on prevalence,
impact, and difficulty, it is recommended that POCUS curricula in
HIV/TB endemic settings focus on FASH, heart, and DVT, while
kidney, liver, and gynaecology applications can be reserved for
physicians more experienced with US and those with a specific
interest in these fields. This review focused on the literature in Sub-
Saharan Africa, but, depending on the epidemiology of HIV, TB, and
other illnesses, POCUS has the potential to inform decisions
regarding treatment management in other resource-limited
settings, such as Latin America and Southeast Asia.
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